| PERIOD ENDING | 28-Sep-09 | 29-Jun-09 | 30-Mar-09 | 29-Dec-08 | | Total Revenue | 30,033 | 31,636 | 28,666 | 30,735 | | Cost of Revenue | 27,259 | 26,855 | 25,813 | 27,297 | | | Gross Profit | 2,774 | 4,781 | 2,853 | 3,438 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,689 | 3,533 | 4,171 | 3,429 | | Non Recurring | 44 | 205 | 47 | 6,301 | | Others | 1,463 | 2,017 | 1,964 | 2,090 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,422) | (974) | (3,329) | (8,382) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 61 | 7 | 4 | 14 | | Earnings Before Interest And Taxes | (2,361) | (967) | (3,325) | (8,368) | | Interest Expense | 1 | 2 | 1 | 2 | | Income Before Tax | (2,362) | (969) | (3,326) | (8,370) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,362) | (969) | (3,326) | (8,370) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,362) | (969) | (3,326) | (8,370) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,362) | ($969) | ($3,326) | ($8,370) |
|
0.11% Nasdaq 
Income Statement
